Association of the CYP17 gene polymorphism with risk for uterine leiomyoma in Brazilian women

Gynecological Endocrinology

Volumn 24, Issue 7, 2008, Pages 373-377

  Vieira, Lucinda Coelho Esperança ^a,b   Gomes, Mariano Tamura Vieira ^a   Castro, Rodrigo De Aquino ^a   De Souza, Naiara Correia Nogueira ^a   Da Silva, Ismael Dale Cotrim Guerreiro ^a   Baracat, Edmund Chada ^a   Girão, Manoel João Batista Castello ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

CYP17; Hormone metabolism; Polymorphism; Single nucleotide polymorphism; Uterine fibroids; Uterine leiomyoma

Indexed keywords

CYTOCHROME P450 17;

ADULT; AGED; ARTICLE; BRAZIL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; UTERUS MYOMA;

AGED; BRAZIL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEIOMYOMA; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE; UTERINE NEOPLASMS;

EID: 47749149195     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590802131830     Document Type: Article

References (35)

1. Buttram VC, Reiter RC. Uterine leiomyomata: etiology, symptomatology and management. Fertil Steril 1981;36:433-445.
2. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, Willett WC, Hunter DJ. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 1997;90:967-973.
3. Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 2004;104:393-406.
4. Olive DL, Lindhein SR, Pritts EA. Non-surgical management of leiomyoma: impact on fertility. Curr Opin Obstet Gynecol 2004;16:239-243.
5. Gambone JC, Reiter RC. Hysterectomy: improving the patient's decision-making process. Clin Obstet Gynecol 1997;40:868-877.
6. Maruo T, Matsuo H, Samoto T, Shimomura Y, Kurachi O, Gao Z, Wang Y, Spitz IM, Johansson E. Effects of progesterone on uterine leiomyoma growth and apoptosis. Steroids 2000;65:585-592.
7. Huber JC, Schneeberger C, Tempfer CB. Genetic modeling of the estrogen metabolism as a risk factor of hormone-dependent disorder. Maturitas 2002;42:1-12.
8. Kado N, Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Tsukamoto K, Hasegawa G, Nakamura N, Yohikawa T, et al. Association of the CYP17 gene and CYP19 gene polymorphism with risk of endometriosis in Japanese women. Hum Reprod 2002;17:897-902.
9. Picado-Lenard J, Miller W. Cloning and sequencing of the human gene for P450c17. DNA 1987;6:439-448.
10. Carey A, Waterworth D, Patel K, White D, Little J, Novelli P, Franks S, Williamson R. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994;3:1873-1876.
11. Kristensen VN, Haraldsen EK, Anderson KB, Lonning PE, Erikstein B, Karesen R, Gabrielsen OS, Borresen-Dale AL. CYP17 and breast cancer risk: the polymorphism in the 5′ flanking area of the gene does not influence binding to Sp-1. Cancer Res 1999;59:2825-2828.
12. Feilgelson H, Shames L, Pike M, Coetzee G, Stanczyk F, Henderson B. Cytochrome P450c17α gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res 1998;58:585-587.
13. Haiman C, Hankinson S, Spiegelman D, Colditz G, Willett W, Speizer F, Kelsey KT, Hunter DJ. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 1999;59:1015-1020.
14. Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 1997;57:1063-1065.
15. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SDJ. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci U S A 2003;100:177-182.
16. Gattas GJF, Soares-Vieira JA. Cytochrome P450-2E1 and glutathione S transferase polymorphism among Caucasians mulattoes from Brazil. Occup Med 2000;50:508-511.
17. Nussbaum RL, McInnes RR, Willard HF. Thompson and Thompson: Genetics in medicine. 6th rev. ed. Philadelphia (PA): WB Saunders; 2001. pp 83-95.
18. Hsieh YY, Chang CC, Tsai FJ, Tsai HD, Yeh LS, Lin CC, Tsai CH. Estrogen receptor thymine-adenine dinucleotide repeat polymorphism is associated with susceptibility to leiomyoma. Fertil Steril 2003;79:96-99.
19. Villanova FE, Andrade PM, Otsuka AY, Gomes MTV, Leal ES, Castro RA, Girão MJBC, Nishimura E, Baracat EC, Silva IDCG. Estrogen receptor α polymorphism and susceptibility to uterine leiomyomas. Steroids 2006;11-12:950-955.
20. Massart F, Becherini L, Marini F, Noci I, Piciocchi L, Del Monte F, Masi L, Falchetti A, Tanini A, Scarselli G, et al. Analysis of estrogen receptor (ERα and ERβ) and progesterone receptor (PR) polymorphisms in uterine leiomyomas. Med Sci Monit 2003;9:BR25-BR30.
21. Gomes MTV, Castro RA, Villanova FE, Silva IDCG, Baracat EC, Lima GR, Girão MJBC. The progesterone receptor gene polymorphism, PROGINS, may be a factor related to the development of uterine fibroids. Fertil Steril 2007;87:1116-1121.
22. Fujimoto J, Hirose R, Sakaguchi H, Tamaya T. Expression of size-polymorphic androgen receptor gene in uterine leiomyoma according to the number of cytosine, adenine, and guanine repeats in androgen receptor alleles. Tumour Biol 2000;21:33-37.
23. Hashimoto K, Azuma C, Kamiura S, Koyama M, Nobunaga T, Tokugawa Y, Kimura T, Kubota Y, Sawai K, Saji F. Maintenance of imprinting of the insulin-like growth factor II gene (IGF2) and the small nuclear ribonucleoprotein polypeptide N gene (SNRPN) in the human uterus and leiomyoma. Gynecol Obstet Invest 1996;41:50-54.
24. Habuchi T, Liging Z, Suzuki T, Sasaki R, Tsuchiya N, Tachiki H, Shimoda N, Satoh S, Sato K, Kakehi Y, et al. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a gene dosage effect. Cancer Res 2000;60:5710-5713.
25. Diamanti-Kandarakis E, Bartzis MI, Zapanti ED, Spina GG, Filandra FA, Tsianateli TC, Bergiele AT, Kouli CR. Polymorphism T→C (-34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome. Ferti Steril 1999;71:431-435.
26. Haiman CA, Hankinson SE, Colditz GA, Hunter DJ, DeVivo J. A polymorphism in CYP17 and endometrial cancer risk. Int J Cancer 2000;86:436-439.
27. Marshal RD, Fejzo MLS, Friedman AJ, Mitchner N, Nowak RA, Rein MS, Morton CC, Sktar J. Analysis of androgen receptor DNA reveals the independent clonal origin of uterine leiomyoma and secondary nature of cytogenetic aberrations in the development of leiomyomata. Gen Chrom Cancer 1994;11:1-6.
28. Gloudemans T, Pospiech I, Van Der Ven LTM, Lips CJM, Den Otter W, Sussenbach JS. An AvaII restriction fragment length polymorphism in the insulin-like growth factor II gene and the occurrence of smooth muscle tumors. Cancer Res 1993;53:5754-5758.
29. Patrikis MI, Bryan EJ, Thomas NA, Rice GE, Quinn MA, Baker MS, Campbell IG. Mutation analysis of the CDP, TP53, and KRAS in uterine leiomyomas. Mol Carcinog 2003;37:61-64.
30. Al-Hendy A, Salama AS. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig 2006;13:136-144.
31. Amant F, Dorling CM, Brabanter J, Vergote I, Lindeque BG, Rensburg J van. A possible role of the cytochrome P450c17α gene (CYP17) polymorphism of uterine leiomyomas from black South African women; a pilot study. Acta Obstet Gynecol Scand 2004;83:234-239.
32. Kado N, Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Tsukamoto K, Hasegawa G, Nakamura N, Yoshikawa T, et al. Association of the CYP17 gene and CYP19 gene polymorphism with risk of endometriosis in Japanese women. Hum Reprod 2002;17:897-902.
33. Tsujino T, Ohara N, Yoshida S, Kennedy S, Takemura N, Deguchi M, Maruo T. The CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population. Gynecol Endocrinol 2006;22:87-91.
34. Denschlag D, Bentz E-K, Hefter L, Pietrowski D, Zeillinger R, Tempfer C, Tong D. Genotype distribution of estrogen receptor-α, catechol-O- methyltransferase, and cytochrome P45017 gene polymorphisms in Caucasian women with uterine leiomyomas. Fertil Steril 2006;85:462-467.
35. Miyoshi Y, Iwao K, Ikeda N, Egawa C, Noguchi S. Genetic polymorphism in CYP17 and breast cancer risk in Japanese women. Eur J Cancer 2000;36:2375-2379.